Herspiegel provides a proven go-to-market commercialization model implemented by an integrated team of experts who are adept at pivoting around rapidly changing regulatory, manufacturing, or market conditions. As a leading provider of commercialization services to pharmaceutical and biotechnology industries, with more than 75 product launches, our team provides insight generation, strategy development, and implementation plans, with expert execution and delivery across commercial functions to help ensure launch success. A good product with high unmet medical needs is no guarantee of success. On average, only 63% of first-time pharmaceutical product launchers achieve a median forecast, compared to 93% of experienced launchers. Our leadership works directly with clients to identify your organization’s unique needs to develop a commercialization and risk mitigation plan. We create a stage-gate plan to determine when to invest in critical resources, ensure early insights to inform your plan, enable the ability to build a core team, and monitor and adjust so you remain agile.
A pharmaceutical and biotech commercial focus, leveraging decades of experience in building unique insights, differentiated strategy, and successful execution across therapeutic areas. Built from best practices in oncology, rare disease, specialty, and primary care markets and customized to address the brand and market dynamics.
A customized commercial implementation team which can include all levels and functions required for commercialization, Chief Commercial Officer down through field representatives, built to order based on your needs all managed and operationalized as a third-party service.
75+ product launches and hundreds of brand commercial projects. Structured launch management process infused with commercial expertise to ensure early risk identification and mitigation and reduce execution timeline slippage.
Comprehensive commercial functional expertise in a team of MBA, Ph.D., M.D., Pharm.D., supplemented with therapeutic area talent based on your need.
Customized approach to fit specific company needs. Variety of support models from fully outsourced commercialization organization to project-based and/or select staff augmentation. Provides the agility to scale down if launch delays require less staffing. Allows manufacturers to retain all rights and royalties to the product at a lower cost than hiring to build out a commercial operation.
Pharmaceutical and biotechnology start-ups are uniquely challenged when launching a new product. They need to navigate a rapidly evolving regulatory and competitive landscape, while building their internal organization and capabilities. Read our white paper to learn the four critical success factors that are crucial to achieving a successful product launch for start-ups.
